ATLASRani Therapeutics (RANI) earnings date: Nov 5, 2026
Rani Therapeutics (RANI) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.05.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RANI
| Last price | $0.55 (-6.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.0% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Rani Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Rani Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Rani Therapeutics. You can switch it off at any time.
Alert me before RANI reportsFree to start. Creating an account takes under a minute.
Notify me when Rani Therapeutics reports
Track RANI free Add Rani Therapeutics to a free ATLAS watchlist and see its next report date in one place.
RANI earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.05 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +5.0% |
| Average move around a report | ±4.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Rani Therapeutics earnings history: last 5 reports
Rani Therapeutics last reported on Aug 13, 2026: EPS of -$0.04 against an estimate of -$0.05 (+20.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.05 | -$0.04 | +20.0% | Beat | -0.9% |
| Jun 8, 2026 | $0.48 | $0.50 | +4.2% | Beat | -2.3% |
| May 28, 2026 | $1.23 | $1.28 | +4.1% | Beat | +0.1% |
| May 15, 2026 | -$0.04 | -$0.04 | 0.0% | In line | -12.4% |
| Apr 27, 2026 | $4.27 | $4.13 | -3.3% | Miss | -7.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RANI
See the fair value, the probability range and the earnings history of Rani Therapeutics on its ATLAS page.
Rani Therapeutics (RANI) stock analysisPlans from €3.99 a month.
Rani Therapeutics earnings: frequently asked questions
When does Rani Therapeutics (RANI) report earnings?
Rani Therapeutics is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for RANI?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.05 per share (USD). Estimates can change before the report.
How often does RANI beat earnings estimates?
Of its last 5 reports with a recorded result, Rani Therapeutics beat the EPS estimate 3 times; the average surprise was +5.0%. Past results do not predict the next one.
How much does RANI move around earnings?
Over its last 5 reports the stock moved an average of 4.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Rani Therapeutics beat earnings estimates last quarter?
Rani Therapeutics last reported on Aug 13, 2026: EPS of -$0.04 against an estimate of -$0.05 (+20.0% surprise), a beat.
How much does RANI usually move in a day?
On a normal trading day the ATLAS model puts RANI’s one-day range at about ±4.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer